GeneChem Therapeutics Venture Fund

GeneChem Therapeutics Venture Fund - Investments & Acquisitions

Show Real Data GeneChem Therapeutics Venture Fund Investments
See all Recent Investments
Date Company Round Amount Co-investors
2011-07-22Argos TherapeuticsDebt - III$3.5MAurora Funds, Forbion Capital Partners, InterSouth Partners, Lumira Capital, and TVM Capital Life Science
2010-09-13Argos TherapeuticsDebt - II$4.85MAAC Capital Partners, Aurora Funds, Becton Dickinson and Company - Respiratory Solutions Business, CDP Capital, Cordova Ventures, Forbion Capital Partners, Harbinger/Aurora Venture Fund, InterSouth Partners, Japan Asia Investment Group, Kirin Pharma Company, Lumira Capital, Mizuho Capital, Morningside Ventures, Oakwood Medical Investors, Pacific Horizon Ventures, Sanders Morris Harris Private Equity, Senmed Medical Ventures, SHV Capital Ventures, Signet Healthcare Partners, TFG Capital Unternehmensbeteiligungsgesellschaft, TVM Capital Life Science, and Vestcorp AG
2008-11-21Argos TherapeuticsSeries C - II$35.2MAurora Capital Group, CDP Capital, Forbion Capital Partners, InterSouth Partners, Japan Asia Investment Group, Kirin Pharma Company, Lumira Capital, Mizuho Capital, Morningside Ventures, and TVM Capital Life Science
2008-04-14Argos TherapeuticsSeries CAurora Capital Group, CDP Capital, Forbion Capital Partners, InterSouth Partners, Japan Asia Investment Group, Kirin Pharma Company, Lumira Capital, Mizuho Capital, Morningside Ventures, and TVM Capital Life Science
2001-09-19Argos TherapeuticsSeries B$39.5MAbenex Capital, Aurora Funds, Becton Dickinson and Company - Respiratory Solutions Business, Cordova Ventures, Harbinger/Aurora Venture Fund, InterSouth Partners, MDS Capital, Oakwood Medical Investors, Pacific Horizon Ventures, Sanders Morris Harris Private Equity, Senmed Medical Ventures, SHV Capital Ventures, Sofinov, Techno Ventures, and TFG Capital Unternehmensbeteiligungsgesellschaft
See all 5 investments